Tunisia holds talks with WHO to secure vaccine against COVID-19 once efficiency proven

October 13, 2020

(TAP) - Director of the Tunis Pasteur Institute Hechmi Louzir said Monday that the Scientific Committee to Combat Coronavirus is holding talks with the World Health Organisation (WHO) with a view to securing the Coronavirus vaccine as soon as its efficiency is proven.

In a statement to TAP, Louzir said that the task force monitoring research into the development of a vaccine against COVID-19 within the scientific committee is in constant contact with the global COVAX initiative, launched by the WHO and involving 92 low- and middle-income countries.

He added that the initiative aims to help member countries benefit from a vaccine against COVID-19 as soon as its efficiency is proven during the third and final phase of clinical trials.

He affirmed that 11 global vaccines have reached the third stage of clinical trials and 4 other vaccines can be developed in the coming weeks. Researches in this field have been conducted in record time, the official pointed out as the development of a vaccine against any disease lasts lasts at least 4 or 5 years.

Hechmi Louzir indicated that experts from the Health Ministry had been tasked with identifying the priority categories to vaccinate against the Coronavirus.


French government offers funding line to...
October 22, 2020
1818 Fund to combat coronavirus: 52 mill...
October 20, 2020
Octapharma announces FDA approval of upd...
October 20, 2020